We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Manufacturing Issues in Warning Letter to Abbott
FDA Cites Manufacturing Issues in Warning Letter to Abbott
July 23, 2010
Abbott Diabetes Care received a warning letter about manufacturing violations at its Alameda, Calif., facility, which makes FreeStyle and Navigator blood glucose monitoring products.